Clinical Trial: Polish Survey on the Efficacy of the Hypercholesterolemia Treatment
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: Centralized Pan-European Survey on the Undertreatment of Hypercholesterolemia. Polish Survey on the Efficacy of the Hypercholesterolemia Treat
Brief Summary: The purpose of the survey is to evaluate the efficacy of treatment of hypercholesterolemia in Polish patients who are currently on lipid- lowering pharmacological therapy . Efficient treatment is defined as achievement of the LDL cholesterol level goals according to the European Society of Cardiology 2007 guidlines.
Detailed Summary:
Sponsor: AstraZeneca
Current Primary Outcome: establish the proportion of patients on lipid lowering pharmacological treatment reaching the LDL-C goals according to ESC 2007 guidelines in general. [ Time Frame: whole study procedure takes place during the one, single patient's visit ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- establish the proportion of patients on lipid lowering pharmacological treatment in primary prevention, reaching the LDL-C goals according to ESC 2007 guidelines for this sub-population [ Time Frame: whole study procedure takes place during the one, single patient's visit ]
- establish the proportion of patients on lipid lowering pharmacological treatment in secondary prevention, reaching the LDL-C goals according to ESC 2007 guidelines for this sub-population [ Time Frame: whole study procedure takes place during the one, single patient's visit ]
- identify determinants (patient and physician characteristics) for undertreatment of hypercholesterolemia. [ Time Frame: whole study procedure takes place during the one, single patient's visit ]
Original Secondary Outcome: Same as current
Information By: AstraZeneca
Dates:
Date Received: November 17, 2010
Date Started: December 2010
Date Completion:
Last Updated: April 3, 2012
Last Verified: April 2012
